OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
Kailin Yang, Ahmed Halima, Timothy A. Chan
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 604-623
Closed Access | Times Cited: 107
Kailin Yang, Ahmed Halima, Timothy A. Chan
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 604-623
Closed Access | Times Cited: 107
Showing 1-25 of 107 citing articles:
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 49
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 49
A Twindrive Precise Delivery System of Platelet-Neutrophil Hybrid Membrane Regulates Macrophage Combined with CD47 Blocking for Postoperative Immunotherapy
Shupei Sheng, Limin Jin, Yan Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 6, pp. 4981-4992
Closed Access | Times Cited: 15
Shupei Sheng, Limin Jin, Yan Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 6, pp. 4981-4992
Closed Access | Times Cited: 15
Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel‐Mediated Reprogramming of Cancer‐Associated Fibroblasts in Osteosarcoma
Hui Wang, Yu Chen, Ran Wei, et al.
Advanced Materials (2023) Vol. 36, Iss. 15
Closed Access | Times Cited: 27
Hui Wang, Yu Chen, Ran Wei, et al.
Advanced Materials (2023) Vol. 36, Iss. 15
Closed Access | Times Cited: 27
Microneedles as Transdermal Drug Delivery System for Enhancing Skin Disease Treatment
Chaoxiong Wu, Qingyu Yu, Chenlu Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5161-5180
Open Access | Times Cited: 12
Chaoxiong Wu, Qingyu Yu, Chenlu Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5161-5180
Open Access | Times Cited: 12
Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach
Subhamay Adhikary, Surajit Pathak, Vignesh Palani, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 217-217
Open Access | Times Cited: 10
Subhamay Adhikary, Surajit Pathak, Vignesh Palani, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 217-217
Open Access | Times Cited: 10
Dendritic nanomedicine enhances chemo-immunotherapy by disturbing metabolism of cancer-associated fibroblasts for deep penetration and activating function of immune cells
Yunkun Li, Xiaoding Shen, Ding Haitao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3680-3696
Open Access | Times Cited: 10
Yunkun Li, Xiaoding Shen, Ding Haitao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3680-3696
Open Access | Times Cited: 10
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 9
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 9
Dual-Responsive Epigenetic Inhibitor Nanoprodrug Combined with Oncolytic Virus Synergistically Boost Cancer Immunotherapy by Igniting Gasdermin E-Mediated Pyroptosis
Yuanyuan Wang, Jingting Wang, Shuo Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 31, pp. 20167-20180
Closed Access | Times Cited: 9
Yuanyuan Wang, Jingting Wang, Shuo Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 31, pp. 20167-20180
Closed Access | Times Cited: 9
Selective deficiency of mitochondrial respiratory complex I subunits Ndufs4/6 causes tumor immunogenicity
Jiaxin Liang, Tevis Vitale, Xixi Zhang, et al.
Nature Cancer (2025)
Closed Access | Times Cited: 1
Jiaxin Liang, Tevis Vitale, Xixi Zhang, et al.
Nature Cancer (2025)
Closed Access | Times Cited: 1
A unified cross-attention model for predicting antigen binding specificity to both HLA and TCR molecules
Chenpeng Yu, Xing Fang, Shiye Tian, et al.
Nature Machine Intelligence (2025)
Closed Access | Times Cited: 1
Chenpeng Yu, Xing Fang, Shiye Tian, et al.
Nature Machine Intelligence (2025)
Closed Access | Times Cited: 1
Understanding the molecular bridges between the drugs and immune cell
Umesh Chandra Dash, Vinayak Nayak, Hiten Shanker Navani, et al.
Pharmacology & Therapeutics (2025) Vol. 267, pp. 108805-108805
Open Access | Times Cited: 1
Umesh Chandra Dash, Vinayak Nayak, Hiten Shanker Navani, et al.
Pharmacology & Therapeutics (2025) Vol. 267, pp. 108805-108805
Open Access | Times Cited: 1
Precision therapeutic targets for HPV-positive cancers: an overview and new insights
Yaw‐Bin Huang, Jiayi Wang, Wenbin Yang, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Yaw‐Bin Huang, Jiayi Wang, Wenbin Yang, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Molecular determinants of immunogenic cell death elicited by radiation therapy
Claudia Galassi, Vanessa Klapp, Takahiro Yamazaki, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 20-32
Open Access | Times Cited: 19
Claudia Galassi, Vanessa Klapp, Takahiro Yamazaki, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 20-32
Open Access | Times Cited: 19
Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy
Raefa Abou Khouzam, Bassam Janji, Jérôme Thiery, et al.
Seminars in Cancer Biology (2023) Vol. 97, pp. 104-123
Closed Access | Times Cited: 18
Raefa Abou Khouzam, Bassam Janji, Jérôme Thiery, et al.
Seminars in Cancer Biology (2023) Vol. 97, pp. 104-123
Closed Access | Times Cited: 18
Covalent Organic Frameworks: Opportunities for Rational Materials Design in Cancer Therapy
Lele Zhou, Qun Guan, Yu‐Bin Dong
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 8
Closed Access | Times Cited: 16
Lele Zhou, Qun Guan, Yu‐Bin Dong
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 8
Closed Access | Times Cited: 16
In-situ vaccination immunotherapy of colorectal cancer with STING agonist-integrated supramolecular nanovectors
Xiaoying Liu, Fangmin Chen, Madiha Saeed, et al.
Nano Today (2024) Vol. 56, pp. 102273-102273
Closed Access | Times Cited: 7
Xiaoying Liu, Fangmin Chen, Madiha Saeed, et al.
Nano Today (2024) Vol. 56, pp. 102273-102273
Closed Access | Times Cited: 7
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors
Yuze Wu, Ming Yi, Mengke Niu, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 739-760
Open Access | Times Cited: 7
Yuze Wu, Ming Yi, Mengke Niu, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 739-760
Open Access | Times Cited: 7
Light‐Activated In Situ Vaccine with Enhanced Cytotoxic T Lymphocyte Infiltration and Function for Potent Cancer Immunotherapy
Xian An, Zhuang Chen, Yi Luo, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 6
Xian An, Zhuang Chen, Yi Luo, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 6
An Immunomodulatory Zinc‐Alum/Ovalbumin Nanovaccine Boosts Cancer Metalloimmunotherapy Through Erythrocyte‐Assisted Cascade Immune Activation
Jing Zhao, Lingxiao Zhang, Li Pin, et al.
Advanced Science (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 14
Jing Zhao, Lingxiao Zhang, Li Pin, et al.
Advanced Science (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 14
A nanodrug provokes antitumor immune responses via synchronous multicellular regulation for enhanced cancer immunotherapy
Keze Hong, Jianrong Cao, Weiting Jiang, et al.
Journal of Colloid and Interface Science (2024) Vol. 678, pp. 750-762
Closed Access | Times Cited: 4
Keze Hong, Jianrong Cao, Weiting Jiang, et al.
Journal of Colloid and Interface Science (2024) Vol. 678, pp. 750-762
Closed Access | Times Cited: 4
Identification of novel KRASG12D neoantigen specific TCRs and a strategy to eliminate off-target recognition
Xiaojian Han, Xiaxia Han, Yanan Hao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Xiaojian Han, Xiaxia Han, Yanan Hao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Effect of perioperative analgesia on immunity in lung cancer
Xiaomin Fan, Ziqi Huang, Z. J. Chen, et al.
Immunobiology (2025) Vol. 230, Iss. 2, pp. 152867-152867
Open Access
Xiaomin Fan, Ziqi Huang, Z. J. Chen, et al.
Immunobiology (2025) Vol. 230, Iss. 2, pp. 152867-152867
Open Access
A Universal Therapeutic Vaccine Leveraging Autologous Pre‐Existing Immunity to Eliminate in Situ Uniformly Engineered Heterogeneous Tumor Cells
Fuhua Wu, Zhaofei Guo, Jialiang Yang, et al.
Advanced Materials (2025)
Closed Access
Fuhua Wu, Zhaofei Guo, Jialiang Yang, et al.
Advanced Materials (2025)
Closed Access
Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors
Vera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Vera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
CBX2 suppresses interferon signaling to diminish tumor immunogenicity via a noncanonical corepressor complex
Y Lin, Huan Jin, Yong She, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 5
Open Access
Y Lin, Huan Jin, Yong She, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 5
Open Access
